Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Apr;59(4):487–490. doi: 10.1038/bjc.1989.101

Small cell lung cancer.

R C Leonard 1
PMCID: PMC2247163  PMID: 2540787

Full text

PDF
487

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan S. G., Hay F. G., McIntyre M. A., Leonard R. C. Prognosis in small cell carcinoma of the lung--relationship to human milk fat globule 2 (HMFG2) antigen and other small cell associated antigens. Br J Cancer. 1987 Oct;56(4):485–488. doi: 10.1038/bjc.1987.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cunningham D., Banham S. W., Hutcheon A. H., Dorward A., Ahmedzai S., Tansey P., Soukop M., Stevenson R. D., Stack B. R., Kaye S. B. High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung. Cancer Chemother Pharmacol. 1985;15(3):303–306. doi: 10.1007/BF00263906. [DOI] [PubMed] [Google Scholar]
  3. Einhorn L. H., Bond W. H., Hornback N., Joe B. T. Long-term results in combined-modality treatment of small cell carcinoma of the lung. Semin Oncol. 1978 Sep;5(3):309–313. [PubMed] [Google Scholar]
  4. Fargion S., Carney D., Mulshine J., Rosen S., Bunn P., Jewett P., Cuttitta F., Gazdar A., Minna J. Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies. Cancer Res. 1986 May;46(5):2633–2638. [PubMed] [Google Scholar]
  5. Green R. A., Humphrey E., Close H., Patno M. E. Alkylating agents in bronchogenic carcinoma. Am J Med. 1969 Apr;46(4):516–525. doi: 10.1016/0002-9343(69)90071-0. [DOI] [PubMed] [Google Scholar]
  6. Holoye P. Y., Kalbfleisch J. The influence of myelosuppression on the response to chemotherapy in small cell bronchogenic carcinoma. Cancer. 1984 Aug 1;54(3):411–415. doi: 10.1002/1097-0142(19840801)54:3<411::aid-cncr2820540307>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  7. Humblet Y., Symann M., Bosly A., Delaunois L., Francis C., Machiels J., Beauduin M., Doyen C., Weynants P., Longueville J. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study. J Clin Oncol. 1987 Dec;5(12):1864–1873. doi: 10.1200/JCO.1987.5.12.1864. [DOI] [PubMed] [Google Scholar]
  8. Ihde D. C., Deisseroth A. B., Lichter A. S., Bunn P. A., Carney D. N., Cohen M. H., Veach S. R., Makuch R. W., Johnston-Early A., Abrams R. A. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J Clin Oncol. 1986 Oct;4(10):1443–1454. doi: 10.1200/JCO.1986.4.10.1443. [DOI] [PubMed] [Google Scholar]
  9. Klastersky J., Nicaise C., Longeval E., Stryckmans P. Cisplatin, adriamycin, and etoposide (CAV) for remission induction of small-cell bronchogenic carcinoma. Cancer. 1982 Aug 15;50(4):652–658. doi: 10.1002/1097-0142(19820815)50:4<652::aid-cncr2820500406>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  10. Livingston R. B. Small-cell lung cancer--whither late intensification? J Clin Oncol. 1986 Oct;4(10):1437–1438. doi: 10.1200/JCO.1986.4.10.1437. [DOI] [PubMed] [Google Scholar]
  11. Sculier J. P., Klastersky J., Stryckmans P. Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation. J Clin Oncol. 1985 Feb;3(2):184–191. doi: 10.1200/JCO.1985.3.2.184. [DOI] [PubMed] [Google Scholar]
  12. Seifter E. J., Ihde D. C. Therapy of small cell lung cancer: a perspective on two decades of clinical research. Semin Oncol. 1988 Jun;15(3):278–299. [PubMed] [Google Scholar]
  13. Slevin M. L., Plant H., Lynch D., Drinkwater J., Gregory W. M. Who should measure quality of life, the doctor or the patient? Br J Cancer. 1988 Jan;57(1):109–112. doi: 10.1038/bjc.1988.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Smith I. E., Evans B. D., Harland S. J., Robinson B. A., Yarnold J. R., Glees J. G., Ford H. T. High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma. Cancer Chemother Pharmacol. 1985;14(2):120–124. doi: 10.1007/BF00434349. [DOI] [PubMed] [Google Scholar]
  15. Smyth J. F., Fowlie S. M., Gregor A., Crompton G. K., Busuttil A., Leonard R. C., Grant I. W. The impact of chemotherapy on small cell carcinoma of the bronchus. Q J Med. 1986 Oct;61(234):969–976. [PubMed] [Google Scholar]
  16. Snaith R. P., Constantopoulos A. A., Jardine M. Y., McGuffin P. A clinical scale for the self-assessment of irritability. Br J Psychiatry. 1978 Feb;132:164–171. doi: 10.1192/bjp.132.2.164. [DOI] [PubMed] [Google Scholar]
  17. Stahel R. A., Mabry M., Skarin A. T., Speak J., Bernal S. D. Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol. 1985 Apr;3(4):455–461. doi: 10.1200/JCO.1985.3.4.455. [DOI] [PubMed] [Google Scholar]
  18. Stewart P., Buckner C. D., Thomas E. D., Bagley C., Bensinger W., Clift R. A., Appelbaum F. R., Sanders J. Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung. Cancer Treat Rep. 1983 Dec;67(12):1055–1059. [PubMed] [Google Scholar]
  19. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES